New York Society For The Relief Of Ruptured & Crippled Maintaining, operating under the name Hospital For Special Surgery, is located in New York, NY. The organization was established in 1946. According to its NTEE Classification (E24) the organization is classified as: Specialty Hospitals, under the broad grouping of Health Care and related organizations. As of 12/2021, Hospital For Special Surgery employed 6,760 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Hospital For Special Surgery is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2020, Hospital For Special Surgery generated $1.3b in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 4.1% each year. All expenses for the organization totaled $1.3b during the year ending 12/2020. While expenses have increased by 5.3% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, Hospital For Special Surgery has awarded 74 individual grants totaling $2,082,659. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2020
Describe the Organization's Mission:
Part 3 - Line 1
PROVIDE THE HIGHEST QUALITY PATIENT CARE, IMPROVE MOBILITY, & ENHANCE THE QUALITY OF LIFE FOR ALL, & ADVANCE THE SCIENCE OF ORTHOPEDIC SURG, RHEUMATOLOGY, & THEIR RELATED DISCIPLINES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
PATIENT CARE: HOSPITAL FOR SPECIAL SURGERY IS COMMITTED TO PROVIDING WORLD-CLASS CARE TO ITS PATIENTS AND HELPING THEM TO REGAIN THEIR MOBILITY, WHILE ALSO ADVANCING RESEARCH INITIATIVES TO EXPLORE AND IMPROVE TREATMENTS FOR ORTHOPEDIC AND RHEUMATOLOGIC CONDITIONS. HOSPITAL FOR SPECIAL SURGERY OPERATED 205 STAFFED BEDS AS OF DECEMBER 31, 2021 AND DECEMBER 31, 2020; AND 39 OPERATING ROOMS AS OF DECEMBER 31, 2021 AND DECEMBER 31, 2020. WE PERFORMED 27,595 SURGERIES, A INCREASE OF 4,201 OVER THE PRIOR YEAR, WHILE NON-SURGICAL OUTPATIENT VISITS NUMBERED 547,472, 113,323 MORE THAN 2020. HOSPITAL FOR SPECIAL SURGERY PROVIDED INPATIENT CARE TO 12,534 PATIENTS, 2 LESS THAN 2020. OF THOSE IN 2021, 12,284 WERE SURGICAL. TOTAL AMBULATORY SURGICAL CASES NUMBERED 15,313, A INCREASE OF 4,023 FROM 2020. THE HOSPITAL HAS A DIVERSE PATIENT POPULATION SERVING THOSE WITH PUBLIC INSURANCE (MEDICARE AND MEDICAID), PRIVATE INSURANCE (VARIOUS PAYORS) AND THE UNINSURED. THE HOSPITAL MAINTAINS A FINANCIAL ASSISTANCE PROGRAM TO ASSIST THOSE THAT CANNOT PAY FOR ITS SERVICES AND PROVIDES NUMEROUS OTHER COMMUNITY BENEFIT PROGRAMS. HOSPITAL FOR SPECIAL SURGERY IS ALSO RECOGNIZED AS A MAGNET HOSPITAL FOR EXCELLENCE IN NURSING CARE. THE HOSPITAL IS RECOGNIZED FOR ITS EXCELLENCE IN PATIENT CARE AND IS CONSISTENTLY RANKED BY U.S. NEWS AND WORLD REPORT IN ITS SPECIALTIES.
RESEARCH: THE RESEARCH DIVISION OF HOSPITAL FOR SPECIAL SURGERY CONTINUED ITS ACTIVITIES IN 2021 TOWARD ENHANCING AND EXPANDING OUR RESEARCH IN MUSCULOSKELETAL DISEASES. RESEARCH AT HOSPITAL FOR SPECIAL SURGERY WORKS TO ADVANCE THE UNDERSTANDING AND TREATMENT OF MUSCULOSKELETAL DISORDERS THROUGH BASIC, TRANSLATIONAL AND CLINICAL RESEARCH AND EDUCATION. THE GOALS ARE TO IDENTIFY GENETIC, ENVIRONMENTAL, CELLULAR, STRUCTURAL AND MOLECULAR MECHANISMS UNDERLYING DISORDERS IMPORTANT IN ORTHOPEDICS, RHEUMATOLOGY AND RELATED DISCIPLINES AND TO DISCOVER EFFECTIVE APPROACHES FOR DIAGNOSIS PREVENTION, AND TREATMENT OF THESE DISORDERS. HSS RESEARCH INSTITUTE (HSSRI) COMPOSED OF BASIC AND TRANSLATIONAL SCIENTISTS HAS CREATED PROGRAMMATIC AREAS THAT HAS ALLOWED US TO MAKE MAJOR CONTRIBUTIONS TO MUSCULOSKELETAL HEALTH. THE PROGRAMMATIC AREAS IN THE HSSRI ADDRESS ORTHOPEDIC AND RHEUMATIC CONDITIONS AND INCLUDE (1) BONE HEALTH AND OSSEOINTEGRATION (2) INFLAMMATION AND ARTHRITIS (3) AUTOIMMUNE RHEUMATIC DISEASES AND (4) JOINT PRESERVATION. THESE PROGRAMS ARE SUPPORTED BY AN ENABLING INFRASTRUCTURE INCLUDING A GENOMICS CENTER, PRECISION MEDICINE LABORATORY, AND EXPERIMENTAL PATHOLOGY. HSSRI HAS ACTIVE COLLABORATIONS WITH THE BIOMECHANICS DEPARTMENT, MANY CLINICAL DEPARTMENTS INCLUDING ORTHOPEDIC SERVICES, RHEUMATOLOGY/MEDICINE, AND IMAGING(RADIOLOGY), AND IS EXPANDING COLLABORATIONS WITH PHYSIATRY, ANESTHESIA AND NEUROLOGY. COMBINING HSSRI EXPERTISE WITH THE VOLUME, BREADTH, AND DEPTH OF PATIENTS SEEN AT HSS TO DEVELOP UNPARALLELED CLINICAL RESEARCH AND POPULATIONS HEALTH OUTCOMES PROGRAMS, HAS FURTHER THE NATIONAL AND INTERNATIONAL VISIBILITY OF OUR INSTITUTION. AS A RESULT OF STRONG INTRA - AND INTER - PROGRAMMATIC INTERACTIONS, AND THE USE OF SHARED CORE RESOURCES, OUR PORTFOLIO OF INNOVATIVE DISCOVERY AND DEVELOPMENT HAS EXPANDED EXPONENTIALLY. TO PROVIDE THE FINAL COMPONENT NEEDED TO ACHIEVE BENCH-TO BEDSIDE RESEARCH, THE RESEARCH INSTITUTE, IN COLLABORATION WITH CLINICIAN RESEARCHERS HAS CREATED A DISTINGUISHED CLINICAL RESEARCH PROGRAM. IN 2021, THE RESEARCH INSTITUTE WAS FUNDED BY AN OPERATING BUDGET OF $48 MILLION, SUPPORTED IN PART BY APPROXIMATELY $39 MILLION IN EXTRAMURAL FUNDS, INCLUDING $10 MILLION FROM FEDERAL GRANTS. THIS RESEARCH RESULTED IN OVER 1,300 PUBLICATIONS AMONG 215 RESEARCHERS IN 2021. HIGHLIGHTS FOR 2021 INCLUDE: CONTINUED ADVANCEMENT OF HSS'S RESEARCH MISSION BY: 1) SUPPORTING AND RETAINING OUR MOST PRODUCTIVE FACULTY, 2) MENTORING THE NEXT GENERATION OF SCIENTISTS, 3) EXPANDING OUR COLLABORATIVE EFFORTS WITH CLINICIANS AND RECRUITMENT OF FULL TIME CLINICAL RESEARCH SCIENTISTS, 4) SUPPORTING THE INFRASTRUCTURE NECESSARY TO ADVANCE OUR RESEARCH AND ENSURE COMPLIANCE, AND 5) SCIENTIFIC HIGHLIGHTS INCLUDE, COVID RELATED RESEARCH AND LABORATORY STUDIES IN AREAS SUCH AS BONE AND IMPLANT INTEGRATION, SPINE DISC DEVELOPMENT, PERIPROSTHETIC JOINT INFECTION, TENDON AND LIGAMENT REPAIR, BIOLOGICS AND AUTOIMMUNE DISEASES (I.E. RHEUMATOID ARTHRITIS, SYSTEMIC SCLEROSIS, LUPUS), REGENERATIVE MEDICINE, AND SINGLE CELL SEQUENCING. REGENERATIVE MEDICINE, AND SINGLE CELL SEQUENCING.
EDUCATION INSTITUTE: HSS EDUCATION INSTITUTE "EI" CONTINUED TO MAKE STRIDES TOWARDS THE MISSION TO BE "THE MOST TRUSTED EDUCATOR" IN THE FIELD OF MUSCULOSKELETAL HEALTH FOR PATIENTS, PHYSICIANS, ALLIED HEALTH PROFESSIONALS AND THE GENERAL PUBLIC. IN 2021 WE STRENGTHENED STRATEGIC PARTNERSHIPS WITH OUR 23 EDUCATION AND ACADEMIC AFFAIRS ADVISORY COMMITTEES AND COUNCILS, AS WELL AS FURTHERING EXTERNAL COMMUNITY RELATIONS GLOBALLY, ENGAGING 32 PARTNER COUNTRIES. THE INSTITUTE TRAINED 47 RESIDENTS, 71 FELLOWS, AND 106 MEDICAL STUDENTS AND TRAINEES WHO SPEND PART OF THE YEAR AT HSS. FOR OTHER TRAINEES, THERE WERE 291 IN-ROTATORS AND 216 CONSULTS. IN ADDITION, HSS' RESIDENCY PROGRAM HAS BEEN TOP RANKED FOR SIX YEARS BY PHYSICIAN NETWORK DOXIMITY IN BOTH REPUTATION AND RESEARCH OUTPUT. IN 2021, WE ENGAGED 6.6 MILLION PEOPLE THROUGH CUTTING EDGE LIVE AND DIGITAL EDUCATION PROGRAMS, INCLUDING OUR HSS E-ACADEMY (THE HOSPITAL'S ONLINE LEARNING PLATFORM FOR PROFESSIONALS), ACGME PROGRAMS, CME ACCREDITED ACTIVITIES, BIOSKILLS EDUCATION LABORATORY SESSIONS, GLOBAL PARTNERSHIP INITIATIVES, KIM BARRETT MEMORIAL MEDICAL LIBRARY USERS, AND COMMUNITY EDUCATION & OUTREACH PROGRAMS. EI ALSO HOSTED 45 ACADEMIC VISITORS AND CREDENTIALED NEARLY 1,450 PHYSICIANS AND HEALTH CARE PROVIDERS. WE CONTINUE TO SET THE HIGHEST STANDARD WITH OUR ACCME ACCREDITED AND NON-ACCREDITED PROFESSIONAL EDUCATION PROGRAMS. IN 2021, THE EDUCATION INSTITUTE THROUGH ITS CONTINUING EDUCATION AND GLOBAL ACADEMIC PARTNERSHIPS DEPARTMENTS, INCLUDING HSS E-ACADEMY DELIVERED MORE THAN 1,800 EDUCATIONAL ACTIVITIES INCLUDING ONSITE COURSES, GRAND ROUNDS, INTERNET LIVE COURSES, INTERNET ENDURING MATERIAL AND JOURNAL-BASED CONTINUING MEDICAL EDUCATION ACTIVITIES RESULTING IN OVER 274,000 LEARNER INTERACTIONS WITH A DIVERSITY OF HEALTHCARE PROFESSIONALS AND TEAMS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Bryan T Kelly Member/surgeon-In-Chief | OfficerTrustee | 76.08 | $5,913,023 |
Louis A Shapiro President & Chief Exec Officer | OfficerTrustee | 45.23 | $5,180,829 |
Answorth A Allen Attending Physician | 49.38 | $2,856,349 | |
Stacey L Malakoff Exec VP & Chief Fin Officer | Officer | 48.23 | $2,767,416 |
Danyal Nawabi Assistant Attending Physician | 50 | $2,753,451 | |
William M Ricci Chief Of The Trauma Service | 50 | $2,594,441 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Tishman Construction Corp Construction | 12/30/21 | $17,181,057 |
Mindstream Media Marketing | 12/30/21 | $5,732,510 |
Proskauer Rose Llp Legal Services | 12/30/21 | $3,602,364 |
Pm Construction Construction | 12/30/21 | $3,816,857 |
Epic Systems Corp Ehr System Services | 12/30/21 | $3,304,034 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $1,717,287 |
Government grants | $131,420,764 |
All other contributions, gifts, grants, and similar amounts not included above | $74,707,715 |
Noncash contributions included in lines 1a–1f | $910,920 |
Total Revenue from Contributions, Gifts, Grants & Similar | $207,845,766 |
Total Program Service Revenue | $1,002,410,494 |
Investment income | $14,333,948 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $516,358 |
Net Rental Income | -$22,329 |
Net Gain/Loss on Asset Sales | $18,537,834 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $1,330,093,726 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $172,000 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $22,414,753 |
Compensation of current officers, directors, key employees. | $7,987,508 |
Compensation to disqualified persons | $843,530 |
Other salaries and wages | $592,477,176 |
Pension plan accruals and contributions | $31,998,945 |
Other employee benefits | $60,678,304 |
Payroll taxes | $35,917,252 |
Fees for services: Management | $14,172,807 |
Fees for services: Legal | $7,710,374 |
Fees for services: Accounting | $321,000 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $350,000 |
Fees for services: Other | $19,798,313 |
Advertising and promotion | $20,916,330 |
Office expenses | $29,334,652 |
Information technology | $34,562,061 |
Royalties | $0 |
Occupancy | $67,999,251 |
Travel | $4,870,456 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $15,436,752 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $87,800,671 |
Insurance | $22,864,746 |
All other expenses | $19,110,383 |
Total functional expenses | $1,284,546,333 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $443,386,847 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $53,261,765 |
Accounts receivable, net | $191,156,986 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $15,032,620 |
Inventories for sale or use | $16,314,726 |
Prepaid expenses and deferred charges | $12,631,869 |
Net Land, buildings, and equipment | $668,753,410 |
Investments—publicly traded securities | $574,321,298 |
Investments—other securities | $394,452,637 |
Investments—program-related | $0 |
Intangible assets | $503,100 |
Other assets | $662,516,774 |
Total assets | $3,032,332,032 |
Accounts payable and accrued expenses | $144,339,647 |
Grants payable | $1,191,937 |
Deferred revenue | $946,667 |
Tax-exempt bond liabilities | $18,936,171 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $537,425,458 |
Unsecured mortgages and notes payable | $100,000,000 |
Other liabilities | $943,949,470 |
Total liabilities | $1,746,789,350 |
Net assets without donor restrictions | $820,577,865 |
Net assets with donor restrictions | $464,964,817 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $3,032,332,032 |
Over the last fiscal year, New York Society For The Relief Of Ruptured & Crippled Maintaining has awarded $520,000 in support to 15 organizations.
Grant Recipient | Amount |
---|---|
West Palm Beach, FL PURPOSE: EARTHQUAKE IN HAITI | $175,000 |
New York, NY PURPOSE: GENERAL SUPPORT | $100,000 |
New York, NY PURPOSE: GENERAL SUPPORT | $40,000 |
BROOKLYN BASEBALL CO LLC PURPOSE: GENERAL SUPPORT | $30,000 |
Sparkill, NY PURPOSE: GENERAL SUPPORT | $25,000 |
North Salem, NY PURPOSE: GENERAL SUPPORT | $25,000 |
Over the last fiscal year, we have identified 26 grants that New York Society For The Relief Of Ruptured & Crippled Maintaining has recieved totaling $8,320,728.
Awarding Organization | Amount |
---|---|
Hospital For Special Surgery Fund Inc New York, NY PURPOSE: ACADEMIC TRAINING & PEDIATRIC OUTREACH | $4,703,642 |
The Tow Foundation Inc New Canaan, CT PURPOSE: LEVERAGING GENOMICS TO PREVENT AND REPAIR TISSUE DAMAGE | $1,120,000 |
Schwab Charitable Fund San Francisco, CA PURPOSE: HEALTH | $888,250 |
Gordon E And Betty I Moore Foundation Palo Alto, CA PURPOSE: TO SUPPORT THE DEVELOPMENT OF A CLINICAL QUALITY MEASURE TO IMPROVE THE DIAGNOSIS OF PERIPROSTHETIC JOINT INFECTION. | $499,259 |
Omega Medical Grants Association Rosemont, IL PURPOSE: FELLOWSHIP | $246,405 |
Rheumatology Research Foundation Atlanta, GA PURPOSE: INNOVATIVE RESEARCH AWARD- TRANASLATIONAL | $200,000 |
Beg. Balance | $468,683,477 |
Earnings | $26,040,976 |
Net Contributions | $154,111,634 |
Other Expense | $63,241,039 |
Ending Balance | $585,595,048 |
Organization Name | Assets | Revenue |
---|---|---|
Connecticut Childrens Medical Center Hartford, CT | $576,292,525 | $449,106,821 |
The American Oncologic Hospital Philadelphia, PA | $214,267,027 | $267,396,349 |
Deborah Heart & Lung Center Browns Mills, NJ | $167,226,252 | $229,369,314 |
Childrens Medical Center Boston, MA | $4,378,412,245 | $224,711,683 |
New York Eye & Ear Infirmary New York, NY | $185,735,136 | $146,385,598 |
Calvary Hospital Inc Bronx, NY | $108,684,200 | $129,369,000 |
Hospital For Special Care New Britain, CT | $171,909,845 | $122,480,911 |
Elizabeth Seton Pediatric Center Yonkers, NY | $164,173,178 | $115,663,526 |
Saint Marys Hospital For Children Inc Bayside, NY | $163,358,524 | $102,313,252 |
Blythedale Childrens Hospital Valhalla, NY | $271,989,720 | $102,411,458 |
Gaylord Hospital Inc Wallingford, CT | $128,915,259 | $93,864,811 |
Good Shepherd Rehabilitation Hosp Allentown, PA | $57,653,412 | $80,489,930 |